Rx License-Rx
← Back to AI Screener Open university listing

LicenseRx asset brief

Phenylthiocarbamide (PTC) Taste Receptor

National Institutes of Health Early / Discovery Biologic
Probability of Success

14% · grade D · Medium data confidence

Model PoS 14% (grade D, medium data confidence). Strongest signals: Competitive whitespace, Licensing readiness. Biggest drag: IP position.

Data maturity (22%) 36

Early / Discovery; limited public evidence of validation.

IP position (16%) 30

Protection lapsed or abandoned -- verify freedom to operate.

Modality feasibility (14%) 66

Biologic/antibody -- solid path but higher CMC burden.

Indication pull (14%) 60

Indication not tagged to a high-appetite area -- confirm market pull.

Competitive whitespace (12%) 86

Under-served segment; multi-modal differentiation.

Translational evidence (12%) 46

No translational evidence keywords in the public summary -- lab-stage claim.

Licensing readiness (10%) 94

Listed as available for licensing; established tech-transfer office; 1 public source link(s).

Unlock the full strategic deep dive

Cost to the next milestone, decisive data, relevant articles, and the partner-ready development plan for this asset.

View Operator access See what's included →